Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders

  • Anna Morozova
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Yana Zorkina
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Olga Abramova
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Olga Pavlova
    Department of Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia
  • Konstantin Pavlov
    Department of Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia
  • Kristina Soloveva
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Maria Volkova
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Polina Alekseeva
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Alisa Andryshchenko
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Georgiy Kostyuk
    Mental-Health Clinic No. 1 Named after N.A. Alekseev, 117152 Moscow, Russia
  • Olga Gurina
    Department of Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia
  • Vladimir Chekhonin
    Department of Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia

説明

<jats:p>This review is focused on several psychiatric disorders in which cognitive impairment is a major component of the disease, influencing life quality. There are plenty of data proving that cognitive impairment accompanies and even underlies some psychiatric disorders. In addition, sources provide information on the biological background of cognitive problems associated with mental illness. This scientific review aims to summarize the current knowledge about neurobiological mechanisms of cognitive impairment in people with schizophrenia, depression, mild cognitive impairment and dementia (including Alzheimer’s disease).The review provides data about the prevalence of cognitive impairment in people with mental illness and associated biological markers.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ